{"date":"2026-04-09","count":26,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7876-2026-04-09-1907-yclg0e","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"19:07:18","subject":"公告本公司因會計師事務所內部輪調更換會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-04-09 19:07，「公告本公司因會計師事務所內部輪調更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-04-09-1903-pu9gcw","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"19:03:07","subject":"本公司董事會決議召開民國115年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-04-09 19:03，「本公司董事會決議召開民國115年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-04-09-1856-8h5bau","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"18:56:36","subject":"本公司董事會決議規劃辦理現金增資私募普通股及(或)國內可轉換公司債","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-04-09 18:56，「本公司董事會決議規劃辦理現金增資私募普通股及(或)國內可轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-04-09-1839-vds8p2","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"18:39:31","subject":"本公司董事會決議通過民國115年員工認股權憑證發行及認股辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-04-09 18:39，「本公司董事會決議通過民國115年員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-04-09-1838-m0l3ow","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-04-09","time":"18:38:35","subject":"公告本公司限制員工權利新股收回註銷完成變更登記","clause":"第36款","fact_date":"2026-04-09","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-04-09 18:38，「公告本公司限制員工權利新股收回註銷完成變更登記」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-04-09-1832-1nbjc38","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-09","time":"18:32:29","subject":"公告本公司庫藏股買回數量達已發行股份總數百分之二","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-04-09 18:32，「公告本公司庫藏股買回數量達已發行股份總數百分之二」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-04-09-1819-48l4hu","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"18:19:12","subject":"本公司董事會決議115年股東常會召開事宜","clause":"第32款","fact_date":"2026-04-09","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-04-09 18:19，「本公司董事會決議115年股東常會召開事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-04-09-1759-1vewhs0","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"17:59:22","subject":"本公司董事會決議以私募方式辦理現金增資發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-04-09 17:59，「本公司董事會決議以私募方式辦理現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-04-09-1758-sdtvjb","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"17:58:40","subject":"公告本公司董事會決議114年度股利不分派說明","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-04-09 17:58，「公告本公司董事會決議114年度股利不分派說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-04-09-1715-yzw1rc","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"17:15:02","subject":"本公司研發之利用自體培養之EB病毒專一性毒殺T細胞對鼻咽癌病患所進行之免疫療法「EBaT8」，獲台灣衛生福利部食品藥物管理署（TFDA）核准進行第一跨二a期臨床試驗。","clause":"第44款","fact_date":"2026-04-09","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-04-09 17:15，「本公司研發之利用自體培養之EB病毒專一性毒殺T細胞對鼻咽癌病患所進行之免疫療法「EBaT8」，獲台灣衛生福利部食品藥物管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-04-09-1700-zx5xun","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"17:00:30","subject":"公告本公司董事會決議召開115年股東常會相關事宜(新增召集事由)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-04-09 17:00，「公告本公司董事會決議召開115年股東常會相關事宜(新增召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-04-09-1647-1tdw1p2","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-04-09","time":"16:47:16","subject":"公告本公司115年3月份自結合併損益","clause":"第53款","fact_date":"2026-04-09","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-04-09 16:47，「公告本公司115年3月份自結合併損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-04-09-1634-1q2r2w9","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"16:34:46","subject":"公告本公司董事會決議不分派114年度股利","clause":"第31款","fact_date":"2026-04-09","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-04-09 16:34，「公告本公司董事會決議不分派114年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-04-09-1631-1fck1r9","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"16:31:50","subject":"公告本公司董事會通過114年度合併財報","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-04-09 16:31，「公告本公司董事會通過114年度合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-04-09-1630-zx5xun","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"16:30:04","subject":"公告本公司董事會決議召開115年股東常會相關事宜(新增召集事由)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-04-09 16:30，「公告本公司董事會決議召開115年股東常會相關事宜(新增召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-04-09-1619-1howjn","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"16:19:38","subject":"公告本公司董事會決議召開115年股東常會","clause":"第32款","fact_date":"2026-04-09","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-04-09 16:19，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-04-09-1615-nq3yxb","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"16:15:41","subject":"公告本公司董事會決議不分派114年度員工酬勞及董事酬勞","clause":"第44款","fact_date":"2026-04-09","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-04-09 16:15，「公告本公司董事會決議不分派114年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-04-09-1614-q8sfg","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"16:14:18","subject":"更正-公告本公司董事會決議召開115年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-04-09 16:14，「更正-公告本公司董事會決議召開115年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-04-09-1614-5j9yh6","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"16:14:09","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-04-09","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-04-09 16:14，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-04-09-1604-1wyd2zg","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"16:04:20","subject":"公告本公司董事會決議撤銷114年現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-04-09 16:04，「公告本公司董事會決議撤銷114年現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-04-09-1553-1hkj5dk","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-04-09","time":"15:53:03","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-04-09 15:53，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-04-09-1533-nhzt8w","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-09","time":"15:33:38","subject":"公告本公司註銷限制員工權利新股變更登記完成","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-04-09 15:33，「公告本公司註銷限制員工權利新股變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-04-09-1531-ec1wid","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-04-09","time":"15:31:26","subject":"公告本公司董事會決議召開民國一一五年股東常會(新增議案)","clause":"第17款","fact_date":"2026-04-09","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-04-09 15:31，「公告本公司董事會決議召開民國一一五年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-04-09-1526-ky9g35","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-04-09","time":"15:26:11","subject":"公告本公司董事會決議辦理私募普通股","clause":"第11款","fact_date":"2026-04-09","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-04-09 15:26，「公告本公司董事會決議辦理私募普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-04-09-1525-7hhrik","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-04-09","time":"15:25:22","subject":"公告本公司董事會通過修訂「第一次買回股份轉讓員工辦法」部分條文","clause":"第53款","fact_date":"2026-04-09","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-04-09 15:25，「公告本公司董事會通過修訂「第一次買回股份轉讓員工辦法」部分條文」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-04-09-1155-15jnz6c","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-04-09","time":"11:55:51","subject":"本公司將於115年4月15日召開創新板上市前業績發表會","clause":"第30款","fact_date":"2026-04-15","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-04-09 11:55，「本公司將於115年4月15日召開創新板上市前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}